<?xml version="1.0" encoding="UTF-8"?>
<fig id="F0004" orientation="portrait" position="float">
 <label>Figure 4.</label>
 <caption>
  <p>Role of RA in protection against the EV-A71 challenge in vivo. (A) An illustration of the treatment with RA in an animal model. (B) Effects of RA on body weight loss of infected mice. Values show the mean ± SD; 
   <italic>n</italic> = 6. (C) Effects of RA on the relief of symptoms of infected mice. Values show the mean ± SD; DMSO group, 
   <italic>n</italic> = 7 and RA group, 
   <italic>n</italic> = 6. (D) Effects of RA on survival of infected mice. The mice survival was estimated using the Kaplan-Meier method; DMSO: 
   <italic>n</italic> = 11, RA: 
   <italic>n</italic> = 10. *
   <italic>P</italic> &lt; 0.05, **
   <italic>P</italic> &lt; 0.01, and ***
   <italic>P</italic> &lt; 0.001.
  </p>
 </caption>
 <alternatives>
  <graphic specific-use="web-only" content-type="black-white" xlink:href="TEMI_A_1767512_F0004_OB" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <graphic specific-use="print-only" content-type="black-white" xlink:href="TEMI_A_1767512_F0004_PB" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </alternatives>
</fig>
